Clinical trial

ACZ885 in Type 1 Diabetes Mellitus

NCT01322321

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE2

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2012-09-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Diabetes Type 1unresolved

Interventions

ACZ885DRUG

PlaceboDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

TorontoOntario, Canada1 MilwaukeeWisconsin, United States1 HanoverGermany1 DüsseldorfGermany1 LiverpoolUnited Kingdom1 BristolUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01322321 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.